Kymera Therapeutics Inc (KYMR)
37.90
-0.71
(-1.84%)
USD |
NASDAQ |
May 10, 16:00
37.85
-0.05
(-0.13%)
After-Hours: 20:00
Kymera Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Immunic Inc | -- |
Insmed Inc | 77.96% |
SELLAS Life Sciences Group Inc | -- |
Iovance Biotherapeutics Inc | -805.6% |
Intellia Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -32.22% |
Return on Assets | -24.21% |
Return on Invested Capital | -32.22% |
Profit Margin (Quarterly) | -472.0% |
Operating Margin (Quarterly) | -514.3% |
Return on Net Operating Assets | -161.0% |